Of the 21 study participants with ovarian cancer, 5 had a P/LP variant in BRCA1 (n = 4) and BRCA2 (n = 1) and were diagnosed with high-grade papillary serous ovarian cancer. The gene discussed is BRCA2; the disease is ovarian cancer.